Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact?
(Q44780567)
scientific article published in March 2004
scientific article published in March 2004
Language:
Current Data About
Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact?
| (P31) |
(Q13442814)
|
||||||||||
| (P50) |
(Q6279267)
|
||||||||||
| (P304) |
759-761
|
||||||||||
| (P407) |
(Q1860)
|
||||||||||
| (P433) |
5
|
||||||||||
| (P478) |
22
|
||||||||||
| (P577) |
Monday, March 1, 2004
|
||||||||||
| (P921) |
(Q974135)
|
||||||||||
| (P1433) |
(Q400292)
|
||||||||||
| (P1476) |
"Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact?" (language: en)
|
other details
| description | scientific article published in March 2004 |
External Links
| (P356) |
10.1200/JCO.2004.12.903
|
| (P698) |
14990627
|